ESMO WCGC 2013 – Video Interview with Prof. Lenz
We ask Professor Heinz-Josef Lenz, Professor of Medicine, Associate Director Clinical Research what he thinks is going to be the next big thing in colorectal cancer for the… read more.
We ask Professor Heinz-Josef Lenz, Professor of Medicine, Associate Director Clinical Research what he thinks is going to be the next big thing in colorectal cancer for the… read more.
FDA Highlights by Bruce Sylvester – Researchers report from a phase I clinical trial report that diffuse, large B-cell lymphomas (DLBCLs) resistant to chemotherapy have been successfully reprogrammed… read more.
Matthias Holdhoff, MD, PHD, Assistant Professor of Oncology. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Dr Jaishri Blakeley, Director, The Johns Hopkins Hospital Comprehensive Neurofibromatosis Center.
Dr Erin Dunbar, Assistant Professor and Co. Director, Preston A. Wells, Jr. Center for Brain Tumor Therapy, Department of Neurosurgery, University of Florida.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
A review of the presentation by Jaume Capdevila, Barcelona Spain. Unfortunately Neuroendocrine tumours (NETs) are often advanced at the time of diagnosis and the 5 year survival ranges… read more.
Poster 67 Elizabeth Goode elizabeth.goode@nnuh.nhs.uk. Chemotherapy is an independent risk factor for thromboembolism (TE), although current guidelines do not recommend routine use of anti-thrombin agents in this setting.